At the end of the latest market close, Epizyme Inc. (EPZM) was valued at $0.59. In that particular session, Stock kicked-off at the price of $0.58 while reaching the peak value of $0.6379 and lowest value recorded on the day was $0.4602. The stock current value is $0.47.Recently in News on May 10, 2022, Epizyme Reports First Quarter 2022 Financial Results and Provides Business Update. TAZVERIK® (tazemetostat) Net Product Revenue of $8.7 Million for 1Q 2022, Supported by Streamlined Operating Expenses which Decreased by 17% in 1Q 2022 vs. 1Q 2021. You can read further details here
Epizyme Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.7500 on 01/04/22, with the lowest value was $0.4602 for the same time period, recorded on 05/11/22.
Epizyme Inc. (EPZM) full year performance was -94.53%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Epizyme Inc. shares are logging -95.26% during the 52-week period from high price, and -17.98% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.57 and $9.86.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1938368 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Epizyme Inc. (EPZM) recorded performance in the market was -81.29%, having the revenues showcasing -72.97% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 77.88M, as it employees total of 250 workers.
Epizyme Inc. (EPZM) in the eye of market guru’s
During the last month, 0 analysts gave the Epizyme Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.5120, with a change in the price was noted -2.49. In a similar fashion, Epizyme Inc. posted a movement of -84.20% for the period of last 100 days, recording 2,681,424 in trading volumes.
Epizyme Inc. (EPZM): Stocks Technical analysis and Trends
Raw Stochastic average of Epizyme Inc. in the period of last 50 days is set at 0.57%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 1.73%. In the last 20 days, the company’s Stochastic %K was 6.33% and its Stochastic %D was recorded 8.92%.
If we look into the earlier routines of Epizyme Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -81.29%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -90.36%, alongside a downfall of -94.53% for the period of the last 12 months. The shares -35.97% in the 7-day charts and went up by -45.26% in the period of the last 30 days. Common stock shares were lifted by -72.97% during last recorded quarter.